Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Prospect Medical Holdings, Inc. (“Prospect” or the “Company”) (Nasdaq: PZZ) relating to the proposed acquisition by an entity sponsored by Leonard Green & Partners, L.P.

Under the terms of the offer, Prospect shareholders would receive cash of $8.50 for each share of Prospect stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law. The transaction appears to be unfair, in part, given that Prospect stock was trading at $7.53 a share as recently as June 14, 2010, and according to Yahoo! Finance an analyst placed a $16.20 target price on the Company. In addition, some officers and directors of the Company have agreed to exchange 6.2 million of their shares for an equity interests in the sponsored purchasing entity.

If you own shares of Prospect and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com, or by calling toll free 877-LEGAL-90.

Copyright Business Wire 2010